Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.

[1]  H. Mallidi,et al.  Heart transplant graft survival is improved after a reduction in panel reactive antibody activity. , 2013, The Journal of thoracic and cardiovascular surgery.

[2]  Dionne A. Graham,et al.  Racial and Ethnic Differences in Wait-List Outcomes in Patients Listed for Heart Transplantation in the United States , 2012, Circulation.

[3]  D. Yuh,et al.  Simple Score to Assess the Risk of Rejection After Orthotopic Heart Transplantation , 2012, Circulation.

[4]  M. Hlatky,et al.  Persistent Racial Disparities in Survival After Heart Transplantation , 2011, Circulation.

[5]  K. Gauvreau,et al.  Improved Survival in Heart Transplant Recipients in the United States: Racial Differences in Era Effect , 2011, Circulation. Heart failure.

[6]  R. Bray,et al.  The evolution and clinical impact of Human Leukocyte Antigen technology , 2010, Current opinion in nephrology and hypertension.

[7]  Ashish S Shah,et al.  The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. , 2010, The Annals of thoracic surgery.

[8]  K. Gauvreau,et al.  Socioeconomic position, ethnicity, and outcomes in heart transplant recipients. , 2010, The American journal of cardiology.

[9]  R. Beygui,et al.  Ethnicity as a predictor of graft longevity and recipient mortality in heart transplantation. , 2007, Transplantation proceedings.

[10]  K. Kokko,et al.  Transplanting the Highly Sensitized Patient: The Emory Algorithm , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  M. Costanzo,et al.  Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care. , 2003, Journal of cardiac failure.

[12]  M. Mehra,et al.  Ethnic Disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression , 2002, Transplantation.

[13]  U. Christians,et al.  The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups , 2001, Clinical pharmacology and therapeutics.

[14]  S. Takemoto,et al.  The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. , 2000, Transplantation.

[15]  P. Kimball,et al.  The impact of race and HLA matching on long-term survival following cardiac transplantation. , 1997, Transplantation proceedings.

[16]  E. Milford,et al.  IMPACT OF RACIAL GENETIC POLYMORPHISM ON THE PROBABILITY OF FINDING AN HLA‐MATCHED DONOR , 1995, Transplantation.

[17]  G. Land,et al.  COMPARISON OF PANEL‐REACTIVE ANTIBODY LEVELS IN CAUCASIAN AND AFRICAN AMERICAN RENAL TRANSPLANT CANDIDATES , 1995, Transplantation.

[18]  A. Steinberg,et al.  The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry. , 1994, Transplantation.

[19]  A. Goh.  Graft survival trends in kidney transplants: an analysis of the UNOS database. , 2009, Clinical transplants.

[20]  P. Nickerson,et al.  Evolution of HLA antibody detection , 2004, Immunologic research.

[21]  S. Katznelson,et al.  Clinical aspects of sensitization. , 1997, Clinical transplants.

[22]  R. Starling,et al.  Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.